{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:26:08Z","timestamp":1779290768846,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.3816\/clc.2007.n.028","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:08:51Z","timestamp":1221080931000},"page":"434-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Malignancy-Related Hypercalcemia Developing on a Bisphosphonate but Responding to Calcitonin"],"prefix":"10.3816","volume":"8","author":[{"given":"Charles J.","family":"Diskin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Dansby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lautrec","family":"Radcliff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLC.2007.n.028_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0025-7125(16)30085-2","article-title":"Hypercalcemic crisis","volume":"79","author":"Edelson","year":"1995","journal-title":"Med Clin North Am"},{"issue":"suppl 1","key":"10.3816\/CLC.2007.n.028_bib2","first-page":"S79","article-title":"Comparative effects of calcitonin and clodronate in hypercalcaemia","volume":"8","author":"Ljunghall","year":"1987","journal-title":"Bone"},{"key":"10.3816\/CLC.2007.n.028_bib3","first-page":"322","article-title":"Metabolic emergencies in the cancer patient","volume":"27","author":"Flombaum","year":"2000","journal-title":"Semin Oncol"},{"issue":"suppl 17","key":"10.3816\/CLC.2007.n.028_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1681\/ASN.V12suppl_1s3","article-title":"Hypercalcemic crisis","volume":"12","author":"Ziegler","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.3816\/CLC.2007.n.028_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0928-0987(03)00108-8","article-title":"Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro","volume":"19","author":"Toyras","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.3816\/CLC.2007.n.028_bib6","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/art.11136","article-title":"Bisphosphonate resistance in Paget's disease of bone","volume":"48","author":"Joshua","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.3816\/CLC.2007.n.028_bib7","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/1078-0432.CCR-04-2531","article-title":"Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors","volume":"11","author":"Onuma","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2007.n.028_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/JPEM.2006.19.2.169","article-title":"Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis","volume":"19","author":"Atabek","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.3816\/CLC.2007.n.028_bib9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1191\/0269216304pm914ra","article-title":"Systematic review of bisphosphonates for hypercalcaemia of malignancy","volume":"18","author":"Saunders","year":"2004","journal-title":"Palliat Med"},{"key":"10.3816\/CLC.2007.n.028_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00774-004-0526-y","article-title":"Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia\/osteoporosis","volume":"22","author":"Papadaki","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.3816\/CLC.2007.n.028_bib11","first-page":"200","article-title":"Renal effects of salmon calcitonin in man","volume":"80","author":"Paillard","year":"1972","journal-title":"J Lab Clin Med"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411708051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411708051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:02:25Z","timestamp":1761505345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411708051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1525730411708051"],"URL":"https:\/\/doi.org\/10.3816\/clc.2007.n.028","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignancy-Related Hypercalcemia Developing on a Bisphosphonate but Responding to Calcitonin","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLC.2007.n.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}